RVNC - Revance Therapeutics, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.21B
Enterprise Value 3893.33M
Trailing P/E N/A
Forward P/E 1-9.51
PEG Ratio (5 yr expected) 1-0.78
Price/Sales (ttm)4,048.40
Price/Book (mrq)7.39
Enterprise Value/Revenue 32,977.78
Enterprise Value/EBITDA 6-8.70

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Sep 30, 2017


Profit Margin 0.00%
Operating Margin (ttm)-34,732.67%

Management Effectiveness

Return on Assets (ttm)-32.89%
Return on Equity (ttm)-65.05%

Income Statement

Revenue (ttm)300k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)0.00%
Gross Profit (ttm)300k
EBITDA -102.72M
Net Income Avi to Common (ttm)-111.48M
Diluted EPS (ttm)-3.81
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)153.44M
Total Cash Per Share (mrq)4.96
Total Debt (mrq)2.73M
Total Debt/Equity (mrq)1.92
Current Ratio (mrq)7.28
Book Value Per Share (mrq)4.59

Cash Flow Statement

Operating Cash Flow (ttm)-80.41M
Levered Free Cash Flow (ttm)-44.76M

Trading Information

Stock Price History

Beta 1.95
52-Week Change 366.26%
S&P500 52-Week Change 323.52%
52 Week High 337.45
52 Week Low 318.00
50-Day Moving Average 334.09
200-Day Moving Average 327.23

Share Statistics

Avg Vol (3 month) 3555.82k
Avg Vol (10 day) 3299.03k
Shares Outstanding 535.77M
Float 22.23M
% Held by Insiders 11.37%
% Held by Institutions 1100.56%
Shares Short 33.11M
Short Ratio 322.31
Short % of Float 330.83%
Shares Short (prior month) 33.56M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A